Status:
COMPLETED
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
Lead Sponsor:
Allergan
Conditions:
Glaucoma, Primary Open Angle
Ocular Hypertension
Eligibility:
All Genders
Brief Summary
The study will evaluate patients diagnosed with primary open angle glaucoma or ocular hypertension who are switched to Lumigan® UD monotherapy for medical reasons in accordance with physician standard...
Eligibility Criteria
Inclusion
- Diagnosed with primary open-angle glaucoma or ocular hypertension
- Previously prescribed intraocular pressure (IOP)-lowering medication with insufficient IOP control and is now being switched to Lumigan® UD for medical reasons
Exclusion
- None
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
1830 Patients enrolled
Trial Details
Trial ID
NCT01853085
Start Date
April 1 2013
End Date
March 1 2014
Last Update
April 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wiesloch, Baden-Wurttemberg, Germany